Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK.
Hodish I, Tal R, Shaish A, Varda-Bloom N, Greenberger S, Rauchwerger A, Breitbart E, Bangio L, Ben-Shushan D, Pfeffer R, Feder B, Waitsman A, Barshack I, Goldberg I, Mazaki-Tovi S, Peled M, Harats D.
Hodish I, et al. Among authors: feder b.
Cancer Biol Ther. 2009 Mar;8(5):424-32. doi: 10.4161/cbt.8.5.7589. Epub 2009 Mar 19.
Cancer Biol Ther. 2009.
PMID: 19276657
Free article.